Welcome, Guest. Please login or register.
May 28, 2022, 04:31:39 pm

Login with username, password and session length


  • Total Posts: 335
  • Total Topics: 191
  • Online Today: 19
  • Online Ever: 518
  • (January 21, 2020, 05:24:49 pm)
Users Online
Users: 0
Guests: 8
Total: 8


Welcome to the Cancer Health Forums, a round-the-clock discussion area for people who have any type of cancer, their friends and family and others with questions about living with cancer. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Cancer Health Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Metabolic Treatment of Cancer  (Read 143 times)

Offline danialthomas

  • Jr. Member
  • **
  • Posts: 58
  • Doctor Of Osteopathy
    • View Profile
    • Thomas Health Blog
Metabolic Treatment of Cancer
« on: May 07, 2022, 09:21:30 am »
For those with aggressive stage-4 cancer, below is an aggressive metabolic (cancer-starving) treatment protocol. Weekly bloodwork (complete blood count, comprehensive metabolic panel, magnesium, phosphorus, and uric acid), weekly EKGs, and daily blood pressures should be monitored, and medication dosages adjusted along the way if necessary. This protocol is compatible with conventional cancer therapy and may serve as a stand-alone treatment to inhibit tumor growth and kill proliferating cancer cells, senescent (dormant) cancer cells, and cancer stem cells.

Vegan (plant-based/low-methionine) and ketogenic (low-carbohydrate), 7 days per week. Make your meals using recipes from these cookbooks:

· Vegan Keto: ISBN-10: 1628603143
· Vegan Ketogenic Diet: ISBN-10: 164152653X
· The Keto Vegan: ISBN-10: 9492788306

Limit your eating to a 10-hour window period so that you are fasting 14 hours a day. For example, eat breakfast at 8:00 am and finish your last bite of food no later than 6:00 pm.
If you are losing weight and are too skinny (cachectic), to help put on weight, consume 1-2 tablespoons of organic MCT oil every 1-2 hours along with 1-2 capsules of conjugated bile acids to help digest the oil.

Dichloroacetate (DCA):
Taken Monday through Thursday only. Start at 10 mg/kg/day the first week and increase the dosage by an additional 10 mg/kg/day each week until you reach 20-40 mg/kg/day (more is better, depending on tolerance). Using a milligram scale, measure out and divide each day’s total dose into two half-doses and stir into 16 ounces of water and take immediately after breakfast and dinner.
Side effects of DCA may include heartburn, nausea, neuropathy, fatigue, confusion, and mood swings. These are kept to a minimum using omeprazole, curcumin, lactobacillus plantarum, MitoQ, and Poly-MVA (see below).

Supporting Medications:
· Diclofenac sodium 25-50 mg: One tablet immediately after breakfast, lunch, and dinner, Monday through Thursday only. Do not lie down for at least 10 minutes after taking this medication. Do not take ibuprofen while on diclofenac.
· Hydroxychloroquine 200 mg: One tablet with lunch, Monday through Thursday only. While taking this medication, you will need to perform an at-home EKG once a week using the AliveCor KardiaMobile device and email a copy of the EKG to your doctor to measure the QT interval. A normal QT interval is less than 450 milliseconds in men and less than 470 milliseconds in women.
· Ivermectin 3 mg: One tablet with breakfast, lunch, and dinner, Monday through Thursday only.
· Metformin ER 500 mg: One tablet with breakfast and dinner, Monday through Thursday only. If oral metformin causes undue nausea, switch to transdermal (topical) administration.
· Naltrexone 4.5 mg: One capsule at bedtime, Monday through Thursday only.
· Omeprazole 20 mg: One tablet 30 minutes before breakfast, Monday through Thursday only.
· Pentoxifylline 400 mg: One tablet with breakfast and dinner, Monday through Thursday only.
· Propranolol ER 60 mg: One tablet at bedtime, Monday through Thursday only. While taking this medication, you need to measure your blood pressure twice daily using a home blood pressure machine and report to your doctor if your blood pressure goes below 90/60.
· Simvastatin 20 mg: One tablet at bedtime, Monday through Thursday only.
· Tamoxifen 10 mg: One tablet daily with breakfast, Monday through Thursday only.
Supporting supplements:
· Aged garlic extract: Two capsules (692 mg total) at bedtime, Monday through Thursday only.
· Beta-hydroxybutyrate (exogenous ketones) 500mg: Four capsules 30 minutes before breakfast and lunch, and two capsules 30 minutes before dinner, 7 days per week.
· Citric acid: Using a milligram scale, measure out 1500 mg (1.5 grams) and stir in 8 ounces of water. Take immediately after breakfast, lunch, and dinner, Monday through Thursday only.
· Curcumin (highly bioavailable): One capsule (500 mg) daily with breakfast, 7 days a week.
· Fisetin (highly bioavailable): Take 7 capsules (311.5 mg total) all at once with breakfast on Monday only.
· Lactobacillus plantarum 1 billion CFUs: One tablet with lunch, 7 days a week.
· Magnesium gluconate 500 mg: One capsule with breakfast and dinner, 7 days a week.
· MitoQ (ubiquinol) 10 mg: One capsule with breakfast and dinner, Monday through Thursday only.
· Poly-MVA: Using a graduated cylinder, measure and stir 20 mL of Poly-MVA into 4 oz. of water and take 30 minutes before breakfast and dinner, Monday through Thursday only.
· Pro-resolving mediators 500 mg: One capsule with dinner, 7 days a week.
· Sodium selenite time-release 2 mg: Three tablets with breakfast, lunch, and dinner, 7 days a week.

Monitoring treatment effectiveness:
To verify the protocol is working as quickly as possible, get a baseline PET/CT scan and a follow-up scan every other month. If your insurance or Medicare plan does not cover the cost of the PET/CT scan, by going through RadiologyAssist.com, the discounted out-of-pocket cost ranges from $1300 to $2500, depending on where you live.

Continuation and Maintenance:
After achieving remission, in addition to maintaining a healthy diet, continue taking just DCA, but at a reduced dosage of 3 mg/kg/day, Monday through Thursday only. At this low dosage, side effects are minimal or absent altogether.
If additional aggressive steps are needed to help achieve remission, consider intravenous treatment using artesunate and high-dose vitamin C followed by solamargine and low-dose chemotherapy, together with hyperthermia.

Dr. Daniel Thomas, DO, MS
Mount Dora, Florida

For more information:
Anderson, P. Metabolic Therapies in Advanced “Salvage” Cancer Cases. Townsend Letter. August/September 2018: 39-43.
Barancik M, Bohacova V, Gibalova L, Sedlak J, Sulova Z, Breier A. Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells. Int J Mol Sci. 2012;13(1):369-382.
Brohée L, Peulen O, Nusgens B, Castronovo V, Thiry M, Colige AC, Deroanne CF. Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression. Sci Rep. 2018 May 4;8(1):7050.
Capeloa T, Krzystyniak J, Rodriguez AC, Payen VL, Zampieri LX, Pranzini E, Derouane F, Vazeille T, Bouzin C, Duhoux FP, Murphy MP, Porporato PE, Sonveaux P. MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice. Cancers (Basel). 2022 Mar 15;14(6):1488.
Castellanos-Esparza YC, Wu S, Huang L, Buquet C, Shen R, Sanchez-Gonzalez B, García Latorre EA, Boyer O, Varin R, Jiménez-Zamudio LA, Janin A, Vannier JP, Li H, Lu H. Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative MDA-MB-231 breast cancer cells. Int J Oncol. 2018 Apr;52(4):1246-1254.
Cham, B. (2017) Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies. International Journal of Clinical Medicine, 8, 692-713.
Chen H, Zhang H, Cao L, et al. Glucose Limitation Sensitizes Cancer Cells to Selenite-Induced Cytotoxicity via SLC7A11-Mediated Redox Collapse. Cancers (Basel). 2022;14(2):345.
Chen W, An J, Guo J, Wu Y, Yang L, Dai J, Gong K, Miao S, Xi S, Du J. Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness. Cancer Chemother Pharmacol. 2018 May;81(5):885-895.
Dadali, T., Diers, A.R., Kazerounian, S. et al. Elevated levels of mitochondrial CoQ10 induce ROS-mediated apoptosis in pancreatic cancer. Sci Rep 11, 5749 (2021).
da Veiga Moreira J, Hamraz M, Abolhassani M, Schwartz L, Jolicœur M, Peres S. Metabolic therapies inhibit tumor growth in vivo and in silico. Sci Rep. 2019 Feb 28;9(1):3153.
De Preter G, Neveu MA, Danhier P, Brisson L, Payen VL, Porporato PE, Jordan BF, Sonveaux P, Gallez B. Inhibition of the pentose phosphate pathway by dichloroacetate unravels a missing link between aerobic glycolysis and cancer cell proliferation. Oncotarget. 2016 Jan 19;7(3):2910-20.
Di Bello E, Zwergel C, Mai A, Valente S. The Innovative Potential of Statins in Cancer: New Targets for New Therapies. Front Chem. 2020;8:516.
Ebrahimpour S, Tabari MA, Youssefi MR, Aghajanzadeh H, Behzadi MY. Synergistic effect of aged garlic extract and naltrexone on improving immune responses to experimentally induced fibrosarcoma tumor in BALB/c mice. Pharmacognosy Res. 2013 Jul;5(3):189-94.
Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients. 2019;11(10):2376.
Golunski G, Woziwodzka A, Piosik J. Potential Use of Pentoxifylline in Cancer Therapy. Curr Pharm Biotechnol. 2018;19(3):206-216.
Hannon, G., Tansi, F.L., Hilger, I. and Prina-Mello, A. (2021), The Effects of Localized Heat on the Hallmarks of Cancer. Adv. Therap., 4: 2000267.
Hong SE, Jin HO, Kim HA, Seong MK, Kim EK, Ye SK, Choe TB, Lee JK, Kim JI, Park IC, Noh WC. Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin. Biochem Biophys Res Commun. 2016 Jan 8;469(2):164-70.
Icard P, Coquerel A, Wu Z, et al. Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update. Int J Mol Sci. 2021;22(12):6587.
Ishiguro T, Ishiguro RH, Ishiguro M, Toki A, Terunuma H. Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin. Cureus. 2022 Feb 3;14(2):e21884.
Juarez M, Schcolnik-Cabrera A, Dueñas-Gonzalez A. The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. Am J Cancer Res. 2018;8(2):317-331.
Kieliszek M, Lipinski B, Błażejak S. Application of Sodium Selenite in the Prevention and Treatment of Cancers. Cells. 2017 Oct 24;6(4):39.
Lee I, Boucher Y, Demhartner TJ, Jain RK. Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. Br J Cancer. 1994;69(3):492-496.
Lei Y, Yi Y, Liu Y, et al. Metformin targets multiple signaling pathways in cancer. Chin J Cancer. 2017;36(1):17.
Li Z, You Y, Griffin N, Feng J, Shan F. Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy. Int Immunopharmacol. 2018 Aug;61:178-184.
Liang, Y., Hou, L., Li, L. et al. Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway. Oncogene 39, 469–485 (2020).
Liu C, Zheng J, Ou X, Han Y. Anti-cancer Substances and Safety of Lactic Acid Bacteria in Clinical Treatment. Front Microbiol. 2021;12:722052.
Liu T, Zhang J, Li K, Deng L, Wang H. Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy. Front Pharmacol. 2020;11:408.
Lu X, Zhou D, Hou B, Liu QX, Chen Q, Deng XF, Yu ZB, Dai JG, Zheng H. Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer. Cancer Manag Res. 2018;10:1231-1241.
Mantle D, Heaton RA, Hargreaves IP. Coenzyme Q10 and Immune Function: An Overview. Antioxidants (Basel). 2021;10(5):759.
Mikami D, Kobayashi M, Uwada J, Yazawa T, Kamiyama K, Nishimori K, Nishikawa Y, Nishikawa S, Yokoi S, Taniguchi T, Iwano M. β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells. J Pharmacol Sci. 2020 Jan;142(1):1-8.
Mycielska ME, Mohr MTJ, Schmidt K, et al. Potential Use of Gluconate in Cancer Therapy. Front Oncol. 2019;9:522.
Ong CP. High Dose Vitamin C and Low Dose Chemo Treatment. J Cancer Sci. 2018;5(1): 4.
Pantziarka P, Sukhatme V, Bouche G, Meheus L, Sukhatme VP. Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience. 2016; 10:610.
Ren, JG., Seth, P., Ye, H. et al. Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway. Sci Rep 7, 4537 (2017).
Tataranni T, Piccoli C. Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications. Oxid Med Cell Longev. 2019;2019:8201079.
Wang B, Hou D, Liu Q, Wu T, Guo H, Zhang X, Zou Y, Liu Z, Liu J, Wei J, Gong Y, Shao C. Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51. Cancer Biol Ther. 2015;16(10):1548-56.
Weber DD, Aminazdeh-Gohari S, Kofler B. Ketogenic diet in cancer therapy. Aging (Albany NY). 2018;10(2):164-165.
Xu R, Ji Z, Xu C, Zhu J. The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: A systematic review and meta-analysis. Medicine (Baltimore). 2018 Nov;97(46):e12912.
Yang Y, Luo H, Hui K, et al. Selenite-induced autophagy antagonizes apoptosis in colorectal cancer cells in vitro and in vivo. Oncol Rep. 2016;35(3):1255-1264.
Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, Xu M, Ling YY, Melos KI, Pirtskhalava T, Inman CL, McGuckian C, Wade EA, Kato JI, Grassi D, Wentworth M, Burd CE, Arriaga EA, Ladiges WL, Tchkonia T, Kirkland JL, Robbins PD, Niedernhofer LJ. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018 Oct;36:18-28.
Zhang Q, Zhu B, Li Y. Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy. Front Immunol. 2017 Feb 2;8:71.
Zhao J, Zhou R, Hui K, et al. Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells. Oncotarget. 2017;8(12):18832-18847.

This information is for educational purposes only and not intended or implied to be a substitute for professional medical advice, diagnosis, treatment, and monitor­ing by your personal physician. Therefore, I cannot answer questions regarding appropriateness in your situation nor give treatment advice. That is for your personal physician to determine after he or she carefully studies each of the references above.
Located in Mount Dora, Florida, Dr. Thomas is one of the most educated, experienced, and innovative physicians in North America. Over the past 30 years, he has helped people throughout the United States and Canada to prevent and overcome disease, improve their health, slow aging, and increase their lifespan. As an active translational researcher, Dr. Thomas has spent over 35,000 hours poring over the latest scientific discoveries and translating max. discoveries into promising theories


© 2022 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.